laitimes

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

author:Zifu Medical

We do cancer treatment doctors

The last thing I want to see is the word "late."

The most important thing I want to say to everyone is the word "early"

On the morning of March 7, Wang Guiqi, member of the National Committee of the Chinese People's Political Consultative Conference and director of the Endoscopy Department of the Cancer Hospital of the Chinese Academy of Medical Sciences, said so.

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

When the two sessions of the National People's Congress were carried out, cancer prevention and treatment became one of the hot topics of discussion, and many deputies and members made suggestions and suggestions on the prevention and treatment of early screening of cancer.

Symptoms of early tumors are asymptomatic

"What are the symptoms of an early tumor?" There are no symptoms, no typical symptoms. Member Wang Guiqi said: "Most people do not go to the hospital until they have symptoms such as fever, inability to eat, and always discomfort. However, once the malignant tumor has obvious symptoms, it is almost already in the middle and advanced stages. Therefore, in the case of thinking that they are very healthy, it is also necessary to carry out early screening and early diagnosis of tumors in a targeted manner. "

Member Wang Guiqi hinted: By staying away from tobacco and alcohol, appropriate activities, reasonable diet, etc., 1/3 of the occurrence of malignant tumors can be prevented.

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

Early screening and early diagnosis are the key to cancer prevention and treatment

Since the opening of the Fifth Session of the 13th National People's Congress in Beijing, many deputies and members have suggested early screening for cancer. Ji Jiafu, member of the National Committee of the Chinese People's Political Consultative Conference and president of Peking University Cancer Hospital, Hua Yawei, member of the National Committee of the Chinese People's Political Consultative Conference and vice president of Henan Provincial Cancer Hospital, Academician Yu Jinming, deputy to the National People's Congress, and Gu Jin, deputy to the National People's Congress and president of Peking University Shougang Hospital, have said that early detection, early diagnosis and early treatment are the key to cancer prevention and treatment. Early screening and diagnosis are important to intervene in cancer treatment as early as possible, reduce morbidity and mortality, and improve patient survival.

Member Wang Guiqi said that there has never been a "tumor that suddenly occurred." Like the high incidence of esophageal cancer, stomach cancer, colorectal cancer in the mainland, from normal to intermediate and advanced cancer is generally 10 to 15 years.

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

If there are tumor risk factors and high-risk groups, whether you have symptoms or not, at the age of 50, you should take the initiative to do screening, do early diagnosis, do gastrointestinal endoscopy, and avoid the occurrence of advanced stages.

"In 2012, about 28 million cases of gastrointestinal endoscopy were completed nationwide, and by 2021, this data is about 38 million cases, and in the past 10 years, the annual number of examinations has increased by 10 million cases, and the demand for examination by the people is still very strong." Director Wang Guiqi introduced, "According to the guidelines, there are 190 million people in the mainland who are at high risk of gastrointestinal tract, and if these people all go to gastrointestinal endoscopy, the gap between supply and demand is still huge between the two figures of 38 million and 190 million." ”

At present, the mainland's screening and early diagnosis technology has been able to detect early cancer and precancerous lesions, and then through super minimally invasive technology, in the case of preserving human organs and ensuring postoperative quality of life, to treat and even cure these diseases.

Sensorless endoscopy helps stomach cancer to be screened and diagnosed early

A large number of scientific research and clinical practice have shown that stomach cancer should be intervened from the embryo of the disease, and it should start from early screening, early diagnosis and early treatment. In the field of gastric cancer, the most common screening methods are serological testing and gastroscopy.

As the gold standard for the diagnosis of gastric cancer, gastroscopy is of undoubted importance, but this examination method relies on equipment and physician resources, and is an invasive examination, which causes pain to patients, so the population acceptance is low, and it is difficult to use for large-scale screening of gastric cancer in the mainland. Studies on other countries with high incidence of stomach cancer in East Asia also show that gastroscopy is used for gastric cancer screening, the participation of the general population is not high, and medical resources are relatively insufficient, and the promotion of screening work faces serious constraints.

Therefore, using non-invasive diagnostic methods to screen people at high risk of gastric cancer, magnetron capsule gastroscope is a powerful tool.

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

It is understood that when the subject receives a magnetron capsule gastroscopy, he only needs to swallow a mini gastroscopic capsule with water, without intubation or anesthesia, and can complete a comfortable, cross-infection-free, safe and reliable gastroscopy examination in 10-15 minutes. This is also the reason why in recent years, Dasheng ® magnetron capsule gastroscoscopy has been recognized and praised by more and more subjects and medical institutions.

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

Indications for gastroscopy of magnetron capsules

Best Indications:

Reluctance or intolerance to traditional gastroscopy (including painless gastroscopy) or high risk of traditional gastroscopy

Health management (physical examination) gastric examination of the population

Initial screening for gastric cancer (superficial tumors, etc.).

Detection and follow-up of lesions such as gastric ulcers, gastric polyps, varicose veins of the gastric base, and erosive or atrophic gastritis

Evaluation and monitoring of drug-associated gastrointestinal mucosal injury

Contactless (with remote control) endoscopic inspection

Relative indications:

Acute upper gastrointestinal bleeding (hemodynamically stable)

Varicose veins of the esophagus and Barrett's esophagus

Duodenal ulcer and duodenal polyps

Postoperative follow-up and follow-up of partial gastric resection and endoscopic minimally invasive therapy

If the small intestine examination can be completed after the gastric examination, the indication is the same as the endoscopy of the small intestine capsule

Members of the two sessions talked about cancer prevention, early screening, early diagnosis and early treatment as the key

Indications and contraindications to gastroscopy in magnetron capsules

suggestion:

Those over 40 years of age who meet any of the following conditions should be listed as a high-risk group for gastric cancer and need to be screened for stomach cancer regularly.

●People in areas with a high incidence of gastric cancer;

●Helicobacter pylori infection;

●Previous precancerous diseases of the stomach such as chronic atrophic gastritis, gastric ulcer, gastric polyps, postoperative residual stomach, hypertrophic gastritis, and pernicious anemia;

●First-degree relatives of patients with gastric cancer;

●Presence of other risk factors for stomach cancer (high salt, pickled diet, smoking, heavy alcohol consumption, etc.).

Depending on Helicobacter pylori infection, atrophy, heterosexual hyperplasia, etc., screening is carried out every 3-6 months, 1 year, 2 years, and 3 years.